Skip to main navigation

menu

Aclaris - Corp Menu

About Us »
« Back
Research »
« Back
Partnerships
Products
Careers
Citizenship »
« Back
Insights
Investors »
« Back

Aclaris - Extras Menu

Media resources
Contact us

Aclaris - Corp Menu

About Us »
« Back
Research »
« Back
Partnerships
Products
Careers
Citizenship »
« Back
Insights
Investors »
« Back

Aclaris - Investor Relations

Investor Overview
Stock Information
Press Releases
Events
SEC Filings
Corporate Governance
Investor Presentations
Investor FAQs
Email Alerts

Investor Contact

For investor related questions, please email

investors@aclaristx.com

Investor Overview

Stock quote

VOLUME:

View stock performance »

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Overview

Press Releases

February 25, 2021

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

February 22, 2021

Aclaris Therapeutics to Participate in Upcoming Investor Conferences

February 10, 2021

Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

Events

Mar 16, 2021
10:00 AM EDT

Aclaris Therapeutics, Inc. at Oppenheimer 31st Annual Healthcare Conference

Mar 9, 2021
7:00 AM EST

Aclaris Therapeutics, Inc. at H.C. Wainwright Global Life Sciences Conference

Feb 25, 2021
8:00 AM EST

Aclaris Therapeutics, Inc. at 10th Annual SVB Leerink Global Healthcare Conference

Feature Presentation

Aclaris Therapeutics Company Overview - February 2021

Aclaris - Footer Menu

Terms of Use
Privacy Policy
Contact Us
Fraudulent Activity Notice

© 2021 Aclaris Therapeutics, Inc. All rights reserved. Unless otherwise noted, all trademarks referenced on this page are owned by Aclaris Therapeutics.